Liver fibrosis, a progressive scarring of nan liver tissue, represents a awesome world wellness load pinch constricted curen options. It is chiefly driven by nan activation of hepatic stellate cells (HSCs), which proliferate and secrete excess extracellular matrix proteins. Effective strategies to inactivate aliases destruct these activated HSCs are important for reversing fibrosis. However, existent therapies often deficiency precision and efficiency.
Recently, nan squad of Shao Jiangjuan/Zheng Shizhong/Cheng Haibo from Nanjing University of Chinese Medicine revealed a dual regulatory mechanism: inhibition of SIRT7 by Oroxylin A (OA) reprograms nan destiny of HSCs done PRMT5 succinylation-driven senescence and ecto-calreticulin (ecto-CRT)-dependent NK compartment immune clearance. The study achieved a important simplification successful fibrosis markers successful experimental models and highlighted nan captious domiciled of inhibiting nan SIRT7 protein.
Targeting SIRT7 unlocks a dual cytotoxic and immunogenic programme against activated HSCs. Natural compounds for illustration OA connection multi-targeted therapeutic potential. Our findings uncover an businesslike strategy for reprogramming HSCs destiny and supply a promising campaigner for anti-fibrotic therapy."
Jiangjuan Shao, lead author
Professor Shao is from nan Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia Media astatine Nanjing University of Chinese Medicine.
Dual system for HSCs destiny reprogramming
OA, a bioactive compound derived from nan accepted Chinese herb Scutellaria baicalensis, was identified to straight hindrance and inhibit SIRT7, a macromolecule highly expressed successful activated HSCs. This relationship initiates a dual anti-fibrotic program: First, OA-induced SIRT7 inhibition promotes succinylation and proteasomal degradation of PRMT5, activating nan cGAS-STING pathway and triggering irreversible HSCs senescence. Second, SIRT7 blockade—independent of its desuccinylase activity—leads to externalization of calreticulin (ecto-CRT) connected HSCs. This "eat-me" awesome facilitates nickname and elimination by NK cells via nan NKp46 receptor.
Selective and recyclable anti-fibrotic effects
The researchers recovered that OA exhibits precocious selectivity for activated HSCs pinch bully biocompatibility. The compound besides demonstrated reusability and stableness successful its anti-fibrotic effects. In vivo experiments showed singular regression of liver fibrosis, supporting its therapeutic potential. The selectivity stems from circumstantial SIRT7 targeting and consequent immune-dependent clearance, minimizing off-target effects.
"Combatting fibrosis requires integrated manipulation of some cellular aging and immune recognition," Professor Shao said. "The analyzable crosstalk betwixt HSCs and nan immune microenvironment underscores nan request for smart targeting strategies. Our attack provides a synergistic and sustainable solution for fibrosis treatment.
Source:
Journal reference:
Wang, J., et al. (2025). Dual Roles of SIRT7 Inhibition by Oroxylin A Reprogram HSCs Fate: PRMT5 Succinylation-Driven Senescence and Ecto-Calreticulin-Dependent NK Cell Immune Clearance successful Liver Fibrosis. Research. doi.org/10.34133/research.0808
English (US) ·
Indonesian (ID) ·